Report Detail

Pharma & Healthcare Global Prostaglandin E2 Receptor EP2 Subtype Market Insights, Forecast to 2025

  • RnM2888586
  • |
  • 06 February, 2019
  • |
  • Global
  • |
  • 112 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Prostaglandin E2 Receptor EP2 Subtype market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Prostaglandin E2 Receptor EP2 Subtype market based on company, product type, end user and key regions.

This report studies the global market size of Prostaglandin E2 Receptor EP2 Subtype in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostaglandin E2 Receptor EP2 Subtype in these regions.
This research report categorizes the global Prostaglandin E2 Receptor EP2 Subtype market by top players/brands, region, type and end user. This report also studies the global Prostaglandin E2 Receptor EP2 Subtype market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Amgen Inc.
Ascendis Pharma A/S
Ono Pharmaceutical Co., Ltd.
Sanofi
Santen Pharmaceutical Co., Ltd.

Market size by Product
TG-4155
SAR-366234
ONO-8055
Treprostinil
Others
Market size by End User
Clinic
Hospital
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Prostaglandin E2 Receptor EP2 Subtype market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Prostaglandin E2 Receptor EP2 Subtype market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Prostaglandin E2 Receptor EP2 Subtype companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Prostaglandin E2 Receptor EP2 Subtype submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Prostaglandin E2 Receptor EP2 Subtype are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostaglandin E2 Receptor EP2 Subtype market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Prostaglandin E2 Receptor EP2 Subtype Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by Product
      • 1.4.2 TG-4155
      • 1.4.3 SAR-366234
      • 1.4.4 ONO-8055
      • 1.4.5 Treprostinil
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size Growth Rate by End User
      • 1.5.2 Clinic
      • 1.5.3 Hospital
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Prostaglandin E2 Receptor EP2 Subtype Market Size
      • 2.1.1 Global Prostaglandin E2 Receptor EP2 Subtype Revenue 2014-2025
      • 2.1.2 Global Prostaglandin E2 Receptor EP2 Subtype Sales 2014-2025
    • 2.2 Prostaglandin E2 Receptor EP2 Subtype Growth Rate by Regions
      • 2.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales by Regions
      • 2.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Prostaglandin E2 Receptor EP2 Subtype Sales by Manufacturers
      • 3.1.1 Prostaglandin E2 Receptor EP2 Subtype Sales by Manufacturers
      • 3.1.2 Prostaglandin E2 Receptor EP2 Subtype Sales Market Share by Manufacturers
      • 3.1.3 Global Prostaglandin E2 Receptor EP2 Subtype Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prostaglandin E2 Receptor EP2 Subtype Revenue by Manufacturers
      • 3.2.1 Prostaglandin E2 Receptor EP2 Subtype Revenue by Manufacturers (2014-2019)
      • 3.2.2 Prostaglandin E2 Receptor EP2 Subtype Revenue Share by Manufacturers (2014-2019)
    • 3.3 Prostaglandin E2 Receptor EP2 Subtype Price by Manufacturers
    • 3.4 Prostaglandin E2 Receptor EP2 Subtype Manufacturing Base Distribution, Product Types
      • 3.4.1 Prostaglandin E2 Receptor EP2 Subtype Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Prostaglandin E2 Receptor EP2 Subtype Product Type
      • 3.4.3 Date of International Manufacturers Enter into Prostaglandin E2 Receptor EP2 Subtype Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales by Product
    • 4.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue by Product
    • 4.3 Prostaglandin E2 Receptor EP2 Subtype Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Prostaglandin E2 Receptor EP2 Subtype Breakdown Data by End User

    6 North America

    • 6.1 North America Prostaglandin E2 Receptor EP2 Subtype by Countries
      • 6.1.1 North America Prostaglandin E2 Receptor EP2 Subtype Sales by Countries
      • 6.1.2 North America Prostaglandin E2 Receptor EP2 Subtype Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Prostaglandin E2 Receptor EP2 Subtype by Product
    • 6.3 North America Prostaglandin E2 Receptor EP2 Subtype by End User

    7 Europe

    • 7.1 Europe Prostaglandin E2 Receptor EP2 Subtype by Countries
      • 7.1.1 Europe Prostaglandin E2 Receptor EP2 Subtype Sales by Countries
      • 7.1.2 Europe Prostaglandin E2 Receptor EP2 Subtype Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Prostaglandin E2 Receptor EP2 Subtype by Product
    • 7.3 Europe Prostaglandin E2 Receptor EP2 Subtype by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype by Countries
      • 8.1.1 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Sales by Countries
      • 8.1.2 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype by Product
    • 8.3 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype by End User

    9 Central & South America

    • 9.1 Central & South America Prostaglandin E2 Receptor EP2 Subtype by Countries
      • 9.1.1 Central & South America Prostaglandin E2 Receptor EP2 Subtype Sales by Countries
      • 9.1.2 Central & South America Prostaglandin E2 Receptor EP2 Subtype Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Prostaglandin E2 Receptor EP2 Subtype by Product
    • 9.3 Central & South America Prostaglandin E2 Receptor EP2 Subtype by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype by Countries
      • 10.1.1 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Sales by Countries
      • 10.1.2 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype by Product
    • 10.3 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype by End User

    11 Company Profiles

    • 11.1 Amgen Inc.
      • 11.1.1 Amgen Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Amgen Inc. Prostaglandin E2 Receptor EP2 Subtype Products Offered
      • 11.1.5 Amgen Inc. Recent Development
    • 11.2 Ascendis Pharma A/S
      • 11.2.1 Ascendis Pharma A/S Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Ascendis Pharma A/S Prostaglandin E2 Receptor EP2 Subtype Products Offered
      • 11.2.5 Ascendis Pharma A/S Recent Development
    • 11.3 Ono Pharmaceutical Co., Ltd.
      • 11.3.1 Ono Pharmaceutical Co., Ltd. Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Ono Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Products Offered
      • 11.3.5 Ono Pharmaceutical Co., Ltd. Recent Development
    • 11.4 Sanofi
      • 11.4.1 Sanofi Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi Prostaglandin E2 Receptor EP2 Subtype Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi Prostaglandin E2 Receptor EP2 Subtype Products Offered
      • 11.4.5 Sanofi Recent Development
    • 11.5 Santen Pharmaceutical Co., Ltd.
      • 11.5.1 Santen Pharmaceutical Co., Ltd. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Santen Pharmaceutical Co., Ltd. Prostaglandin E2 Receptor EP2 Subtype Products Offered
      • 11.5.5 Santen Pharmaceutical Co., Ltd. Recent Development

    12 Future Forecast

    • 12.1 Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Regions
      • 12.1.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Regions 2019-2025
    • 12.2 Prostaglandin E2 Receptor EP2 Subtype Market Forecast by Product
      • 12.2.1 Global Prostaglandin E2 Receptor EP2 Subtype Sales Forecast by Product 2019-2025
      • 12.2.2 Global Prostaglandin E2 Receptor EP2 Subtype Revenue Forecast by Product 2019-2025
    • 12.3 Prostaglandin E2 Receptor EP2 Subtype Market Forecast by End User
    • 12.4 North America Prostaglandin E2 Receptor EP2 Subtype Forecast
    • 12.5 Europe Prostaglandin E2 Receptor EP2 Subtype Forecast
    • 12.6 Asia Pacific Prostaglandin E2 Receptor EP2 Subtype Forecast
    • 12.7 Central & South America Prostaglandin E2 Receptor EP2 Subtype Forecast
    • 12.8 Middle East and Africa Prostaglandin E2 Receptor EP2 Subtype Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Prostaglandin E2 Receptor EP2 Subtype Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Prostaglandin E2 Receptor EP2 Subtype . Industry analysis & Market Report on Prostaglandin E2 Receptor EP2 Subtype is a syndicated market report, published as Global Prostaglandin E2 Receptor EP2 Subtype Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Prostaglandin E2 Receptor EP2 Subtype market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,100.50
      4,650.75
      6,201.00
      3,607.50
      5,411.25
      7,215.00
      610,038.00
      915,057.00
      1,220,076.00
      325,767.00
      488,650.50
      651,534.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report